 A case of myocardial injury was also reported using Dexatrim (with PPA) at doses recommended for weight control.In 2000, following the request of the FDA to discontinue marketing drug products containing PPA, Dexatrim dropped PPA from its formula.In 2004, FDA banned a second Dexatrim ingredient, ephedra.